Your browser doesn't support javascript.
loading
Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
Mavrogeorgis, Emmanouil; Kondyli, Margarita; Mischak, Harald; Vlahou, Antonia; Siwy, Justyna; Rossing, Peter; Campbell, Archie; Mels, Carina M C; Delles, Christian; Staessen, Jan A; Latosinska, Agnieszka; Persu, Alexandre.
Affiliation
  • Mavrogeorgis E; Mosaiques Diagnostics GmbH, Hannover.
  • Kondyli M; Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University Hospital, Aachen, Germany.
  • Mischak H; University of Patras, Department of Pharmacy, Patras.
  • Vlahou A; Mosaiques Diagnostics GmbH, Hannover.
  • Siwy J; Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
  • Rossing P; Mosaiques Diagnostics GmbH, Hannover.
  • Campbell A; Steno Diabetes Center Copenhagen, Herlev.
  • Mels CMC; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Delles C; Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Staessen JA; Hypertension in Africa Research Team (HART), Faculty of Health Sciences.
  • Latosinska A; MRC Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.
  • Persu A; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
J Hypertens ; 42(8): 1331-1339, 2024 Aug 01.
Article de En | MEDLINE | ID: mdl-38690919
ABSTRACT

OBJECTIVES:

Hypertension is a common condition worldwide; however, its underlying mechanisms remain largely unknown. This study aimed to identify urinary peptides associated with hypertension to further explore the relevant molecular pathophysiology.

METHODS:

Peptidome data from 2876 individuals without end-organ damage were retrieved from the Human Urinary Proteome Database, belonging to general population (discovery) or type 2 diabetic (validation) cohorts. Participants were divided based on systolic blood pressure (SBP) and diastolic BP (DBP) into hypertensive (SBP ≥140 mmHg and/or DBP ≥90 mmHg) and normotensive (SBP <120 mmHg and DBP <80 mmHg, without antihypertensive treatment) groups. Differences in peptide abundance between the two groups were confirmed using an external cohort ( n  = 420) of participants without end-organ damage, matched for age, BMI, eGFR, sex, and the presence of diabetes. Furthermore, the association of the peptides with BP as a continuous variable was investigated. The findings were compared with peptide biomarkers of chronic diseases and bioinformatic analyses were conducted to highlight the underlying molecular mechanisms.

RESULTS:

Between hypertensive and normotensive individuals, 96 (mostly COL1A1 and COL3A1) peptides were found to be significantly different in both the discovery (adjusted) and validation (nominal significance) cohorts, with consistent regulation. Of these, 83 were consistently regulated in the matched cohort. A weak, yet significant, association between their abundance and standardized BP was also observed.

CONCLUSION:

Hypertension is associated with an altered urinary peptide profile with evident differential regulation of collagen-derived peptides. Peptides related to vascular calcification and sodium regulation were also affected. Whether these modifications reflect the pathophysiology of hypertension and/or early subclinical organ damage requires further investigation.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hypertension artérielle Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Hypertens Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hypertension artérielle Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Hypertens Année: 2024 Type de document: Article
...